BlackRock’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-331,810
Closed -$48.1K 5543
2023
Q3
$48.1K Sell
331,810
-1,785
-0.5% -$2.65K ﹤0.01% 5013
2023
Q2
$781K Buy
333,595
+3,543
+1% +$6.58K ﹤0.01% 4350
2023
Q1
$558K Buy
330,052
+36,017
+12% +$93.1K ﹤0.01% 4508
2022
Q4
$920K Buy
294,035
+1,535
+0.5% +$5.08K ﹤0.01% 4431
2022
Q3
$845K Buy
292,500
+286,168
+4,519% +$1.73M ﹤0.01% 4538
2022
Q2
$83K Buy
6,332
+920
+17% +$5.43K ﹤0.01% 5288
2022
Q1
$20K Buy
+5,412
New +$27.8K ﹤0.01% 5569

Other funds holding MKUL

BlackRock's MKUL Position: Q4 2023 in Review

BlackRock sold out of Molekule Group, Inc. Common Stock (MKUL) in Q4 2023, closing a stake of 331,810 shares — an estimated $48.1K sold.

BlackRock first reported a position in MKUL in Q1 2022 and held it in 7 quarters. The position peaked at $920K in Q4 2022. 3 funds tracked by Wall St. Rank hold MKUL as of Q4 2023.

  • BlackRock reported no remaining Molekule Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • BlackRock sold 331,810 Molekule Group, Inc. Common Stock shares in Q4 2023, an estimated $48.1K.
  • BlackRock first reported a position in Molekule Group, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • BlackRock's Molekule Group, Inc. Common Stock position peaked at $920K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q4 2023.

Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.